Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - Nasdaq - IL0010952641 - Common Stock - Currency: USD

65.88  +0.54 (+0.83%)

After market: 65.88 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CAMT. CAMT was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. While CAMT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CAMT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
CAMT had positive earnings in 4 of the past 5 years.
CAMT had a positive operating cash flow in 4 of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

CAMT has a Return On Assets of 12.63%. This is amongst the best in the industry. CAMT outperforms 82.57% of its industry peers.
CAMT has a better Return On Equity (20.69%) than 88.07% of its industry peers.
CAMT's Return On Invested Capital of 11.87% is amongst the best of the industry. CAMT outperforms 82.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CAMT is in line with the industry average of 11.29%.
The 3 year average ROIC (11.38%) for CAMT is below the current ROIC(11.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROIC 11.87%
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 26.53%, CAMT belongs to the best of the industry, outperforming 87.16% of the companies in the same industry.
In the last couple of years the Profit Margin of CAMT has grown nicely.
CAMT's Operating Margin of 23.91% is amongst the best of the industry. CAMT outperforms 83.49% of its industry peers.
In the last couple of years the Operating Margin of CAMT has grown nicely.
CAMT's Gross Margin of 47.80% is in line compared to the rest of the industry. CAMT outperforms 57.80% of its industry peers.
CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CAMT is still creating some value.
There is no outstanding debt for CAMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.51 indicates that CAMT is not in any danger for bankruptcy at the moment.
The Altman-Z score of CAMT (7.51) is better than 76.15% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that CAMT is not too dependend on debt financing.
The Debt to Equity ratio of CAMT (0.38) is worse than 66.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 7.51
ROIC/WACC1.01
WACC11.79%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 5.28 indicates that CAMT has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.28, CAMT is doing good in the industry, outperforming 76.15% of the companies in the same industry.
A Quick Ratio of 4.36 indicates that CAMT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.36, CAMT is in the better half of the industry, outperforming 76.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.28
Quick Ratio 4.36
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.10% over the past year.
The Earnings Per Share has been growing by 34.86% on average over the past years. This is a very strong growth
EPS 1Y (TTM)44.1%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%35.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.25%

3.2 Future

The Earnings Per Share is expected to grow by 12.43% on average over the next years. This is quite good.
Based on estimates for the next years, CAMT will show a quite strong growth in Revenue. The Revenue will grow by 11.44% on average per year.
EPS Next Y15.59%
EPS Next 2Y13.02%
EPS Next 3Y7.89%
EPS Next 5Y12.43%
Revenue Next Year16.15%
Revenue Next 2Y12.19%
Revenue Next 3Y8.72%
Revenue Next 5Y11.44%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 200M 400M 600M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.44 indicates a rather expensive valuation of CAMT.
CAMT's Price/Earnings ratio is a bit cheaper when compared to the industry. CAMT is cheaper than 66.97% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.85, CAMT is valued at the same level.
With a Price/Forward Earnings ratio of 20.28, CAMT is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CAMT is valued a bit cheaper than the industry average as 68.81% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.77. CAMT is around the same levels.
Industry RankSector Rank
PE 23.44
Fwd PE 20.28
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CAMT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.38
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CAMT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)0.67
EPS Next 2Y13.02%
EPS Next 3Y7.89%

More info and screens

0

5. Dividend

5.1 Amount

CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMTEK LTD

NASDAQ:CAMT (5/1/2025, 7:50:28 PM)

After market: 65.88 0 (0%)

65.88

+0.54 (+0.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners50.42%
Inst Owner Change-0.55%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap3.00B
Analysts84
Price Target98.6 (49.67%)
Short Float %13.22%
Short Ratio7.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.39%
Min EPS beat(2)0.71%
Max EPS beat(2)6.06%
EPS beat(4)4
Avg EPS beat(4)5.42%
Min EPS beat(4)0.71%
Max EPS beat(4)8.76%
EPS beat(8)7
Avg EPS beat(8)3.56%
EPS beat(12)9
Avg EPS beat(12)2.39%
EPS beat(16)13
Avg EPS beat(16)4.4%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)1.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.38%
Revenue beat(12)3
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)0.45%
PT rev (1m)-12.12%
PT rev (3m)-10.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 23.44
Fwd PE 20.28
P/S 7.5
P/FCF N/A
P/OCF N/A
P/B 5.84
P/tB 7.06
EV/EBITDA 24.38
EPS(TTM)2.81
EY4.27%
EPS(NY)3.25
Fwd EY4.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.79
BVpS11.27
TBVpS9.33
PEG (NY)1.5
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROCE 13.16%
ROIC 11.87%
ROICexc 26.31%
ROICexgc 36.04%
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
FCFM N/A
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
ROICexc(3y)41.1%
ROICexc(5y)40.46%
ROICexgc(3y)43.5%
ROICexgc(5y)42.07%
ROCE(3y)12.62%
ROCE(5y)12.7%
ROICexcg growth 3Y-14.44%
ROICexcg growth 5Y-8.43%
ROICexc growth 3Y-22.7%
ROICexc growth 5Y-13.87%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 1.95
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.28
Quick Ratio 4.36
Altman-Z 7.51
F-ScoreN/A
WACC11.79%
ROIC/WACC1.01
Cap/Depr(3y)164.71%
Cap/Depr(5y)135.1%
Cap/Sales(3y)2.25%
Cap/Sales(5y)1.89%
Profit Quality(3y)82.16%
Profit Quality(5y)91.7%
High Growth Momentum
Growth
EPS 1Y (TTM)44.1%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%35.09%
EPS Next Y15.59%
EPS Next 2Y13.02%
EPS Next 3Y7.89%
EPS Next 5Y12.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.25%
Revenue Next Year16.15%
Revenue Next 2Y12.19%
Revenue Next 3Y8.72%
Revenue Next 5Y11.44%
EBIT growth 1Y39.52%
EBIT growth 3Y43.47%
EBIT growth 5Y27.24%
EBIT Next Year68.24%
EBIT Next 3Y32.55%
EBIT Next 5YN/A
FCF growth 1Y43.53%
FCF growth 3Y45.38%
FCF growth 5Y37.5%
OCF growth 1Y37.24%
OCF growth 3Y45.5%
OCF growth 5Y36.42%